Tuberculosis News and Research

Latest Tuberculosis News and Research

New model provides better understanding of epidemic spreading in realistic circumstances

New approaches are needed to control the spread of epidemic diseases, according to the developers of a new model of the way pathogens can 'cooperate'.

16 Nov 2017

Comprehensive study of health in India finds improvements, but major inequalities between states

The Lancet publishes the first comprehensive analysis of the health of India’s 1.34 billion citizens—encompassing almost a fifth of the world’s population.

15 Nov 2017

New health analysis in India finds increase in non-communicable diseases

A new state-by-state health analysis in India finds that over two decades heart- and lung-related conditions, as well as other non-communicable diseases (NCDs), have surpassed infectious diseases, such as diarrhea and tuberculosis, as the nation's leading killers.

14 Nov 2017

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

13 Nov 2017

Researchers catch killer cells red-handed in the act of microbial murder

Immune cells called "killer cells" target bacteria invading the body's cells, but how do they do this so effectively? Bacteria can quickly evolve resistance against antibiotics, yet it seems they have not so readily been able to evade killer cells. This has caused researchers to become interested in finding out the exact mechanism that killer cells use to destroy bacterial invaders.

9 Nov 2017

Scientists make significant advance towards creating commercially viable superbug-killing antibiotic

Scientists working to develop a 'game-changing' new antibiotic have made a significant advance towards creating commercially viable drug treatments by producing two simplified synthetic versions of the substance which are just as potent at killing superbugs like MRSA as its natural form.

7 Nov 2017

Malaria detection using breath analyzers

Researchers are on the verge of developing a new breath test that could detect malaria. The team from Washington University in St. Louis found that malaria in blood leaves a typical “breathprint” that is unique and can be detected using a breath analyzer test.

6 Nov 2017

Using biologics during pregnancy may not raise infant's risk for opportunistic infections

Using a biologic therapy to manage rheumatoid arthritis may not significantly increase an infant's risk for developing opportunistic infections like pneumonia, meningitis, and tuberculosis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Scientists solve decade-old mystery that could lead to development of new treatments for TB

Scientists have solved a decade-old mystery that could eventually lead to the development of earlier treatments for one of the world's deadliest diseases, which affects up to 2 billion people.

1 Nov 2017

Neutron crystallography study could open avenues for new drugs to battle diseases

Scientists at the Department of Energy’s Oak Ridge National Laboratory have performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria, and diabetes.

1 Nov 2017

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection.

31 Oct 2017

Study into killer T-cell activity could provide roadmap for tackling antibiotic resistance

In a study that could provide a roadmap for combatting the rising threat of drug-resistant pathogens, researchers have discovered the specific mechanism the body's T cells use to kill bacteria.

27 Oct 2017

ACS recognizes contributions of five surgeons with Surgical Humanitarian and Volunteerism Awards

Last night, five surgeons received the 2017 American College of Surgeons/Pfizer Surgical Humanitarian Awards and Surgical Volunteerism Awards in recognition of their selfless efforts as volunteer surgeons who provide care to medically underserved patients abroad.

23 Oct 2017

Rutgers researchers to explore ways for tackling emerging fungal infections

In recent years, hospitals nationwide have been reporting an increase in life-threatening illnesses resulting from a deadly fungal infection caused by the yeast Candida auris that can enter the bloodstream. This yeast is difficult to identify and often does not respond to commonly used antifungal drugs, leading to high mortality.

23 Oct 2017

Scientists develop novel antimicrobials to tackle multidrug-resistant bacteria

Scientists at the University of Surrey in collaboration with research partners at the University of Sheffield and University of Würzburg, Germany, have developed novel antimicrobials, which could be used to treat infections, caused by multidrug-resistant bacteria.

23 Oct 2017

New model predicts how E. coli bacteria respond to temperature changes, genetic mutations

Researchers at the University of California San Diego have developed a genome-scale model that can accurately predict how E. coli bacteria respond to temperature changes and genetic mutations.

13 Oct 2017

NTNU researchers reveal how HCV converts innocent cells into virus factories

The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus "factories" that quickly go into mass production.

13 Oct 2017

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).

12 Oct 2017

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.

11 Oct 2017

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

10 Oct 2017

Tuberculosis News and Research

Latest Tuberculosis News and Research

New model provides better understanding of epidemic spreading in realistic circumstances

Comprehensive study of health in India finds improvements, but major inequalities between states

New health analysis in India finds increase in non-communicable diseases

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

Researchers catch killer cells red-handed in the act of microbial murder

Scientists make significant advance towards creating commercially viable superbug-killing antibiotic

Malaria detection using breath analyzers

Using biologics during pregnancy may not raise infant's risk for opportunistic infections

Scientists solve decade-old mystery that could lead to development of new treatments for TB

Neutron crystallography study could open avenues for new drugs to battle diseases

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

Study into killer T-cell activity could provide roadmap for tackling antibiotic resistance

ACS recognizes contributions of five surgeons with Surgical Humanitarian and Volunteerism Awards

Rutgers researchers to explore ways for tackling emerging fungal infections

Scientists develop novel antimicrobials to tackle multidrug-resistant bacteria

New model predicts how E. coli bacteria respond to temperature changes, genetic mutations

NTNU researchers reveal how HCV converts innocent cells into virus factories

Academy of Medical Sciences announces new UK-India scheme to address challenge of AMR

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in